| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Off,Svp-r&D | Chief Scientific Off,Svp-r&D | Sr Vp-research &Development +1 more
1 company
Menzaghi Frederique Ph.d. is a Chief Scientific Off,Svp-r&D at Tvardi Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $699K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2018 | TVRD Tvardi Therapeutics, Inc. | Sr Vp-research &Development | Sell | 3,000 | $15.49 | $46,470.00 | -2.7% | |
| May 23, 2018 | TVRD Tvardi Therapeutics, Inc. | Sr Vp-research &Development | Sell | 9,000 | $15.19 | $136,710.00 | -7.6% | |
| Feb 15, 2018 | TVRD Tvardi Therapeutics, Inc. | Sr Vp-research &Development | Sell | 3,000 | $15.02 | $45,060.00 | -2.5% | |
| Jan 24, 2018 | TVRD Tvardi Therapeutics, Inc. | Sr Vp-research &Development | Sell | 15,000 | $15.00 | $225,000.00 | -10.9% | |
| Aug 4, 2017 | TVRD Tvardi Therapeutics, Inc. | Vp-research &Development | Sell | 3,000 | $15.00 | $45,000.00 | -2.5% | |
| Jul 14, 2017 | TVRD Tvardi Therapeutics, Inc. | Vp-research &Development | Sell | 3,000 | $15.00 | $45,000.00 | -2.4% | |
| Apr 20, 2016 | TVRD Tvardi Therapeutics, Inc. | Vp-research &Development | Sell | 6,000 | $9.00 | $54,000.00 | -4.7% | |
| Feb 3, 2016 | TVRD Tvardi Therapeutics, Inc. | Vp-research &Development | Sell | 6,000 | $9.04 | $54,250.00 | -2.3% | |
| Jan 4, 2016 | TVRD Tvardi Therapeutics, Inc. | Vp-research &Development | Sell | 6,000 | $16.80 | $100,800.00 | -4.3% | |
| Dec 1, 2015 | TVRD Tvardi Therapeutics, Inc. | Vp-research &Development | Sell | 6,000 | $16.21 | $97,260.00 | -4.1% |